Stifel analyst Chris O’Cull raised the firm’s price target on Cava Group (CAVA) to $175 from $118 and keeps a Buy rating on the ...

The plaintiffs in the $2.35 million award from last week, Douglas Muhlbauer and related entities, sued Stifel Nicolaus last ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

U.S. inflation remains elevated based on the October CPI report released on Wednesday, complicating the outlook for the Federal Reserve's policy path, according to economists at Stifel, Nicolaus & Co.

A lawyer in the case says his legal team was able to present text messages showing a Stifel wealth manager had been touting complex structured notes as low-risk investments.

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

The stock market is "entering Crazy Town" as valuations creep toward generational highs, Stifel's chief equity strategist ...

Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences. Management plans to participate in the Stife ...

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated ...

Reports indicate that Stifel analyst Erik Rasmussen raised his estimated valuation of the New Zealand rocket-maker by more ...

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full ...

The Haskins Foundation announced Tuesday that Minnesota junior Isabella McCauley (Inver Grove, Heights, Minn.) was one of 25 ...